[{"data":1,"prerenderedAt":402},["ShallowReactive",2],{"article-\u002Fresearch\u002Fmass-spectrometry-peptide-identity":3,"article-compounds-\u002Fresearch\u002Fmass-spectrometry-peptide-identity":364,"article-more-\u002Fresearch\u002Fmass-spectrometry-peptide-identity":387},{"id":4,"title":5,"body":6,"description":334,"extension":335,"faq":336,"meta":346,"navigation":347,"path":348,"publishedAt":349,"readingMinutes":350,"relatedCompounds":351,"seo":355,"stem":356,"tags":357,"updatedAt":362,"__hash__":363},"research\u002Fresearch\u002Fmass-spectrometry-peptide-identity.md","What Mass Spectrometry Establishes That HPLC Cannot",{"type":7,"value":8,"toc":320},"minimark",[9,13,16,19,24,27,30,47,54,57,61,64,67,70,154,162,166,172,178,184,190,194,201,215,218,223,226,236,239,243,246,253,257,260,266,272,278,284,288,291,297,303,306],[10,11,12],"p",{},"A Certificate of Analysis showing 99.4% purity and nothing else tells you the\nvial contains 99.4% of one thing.",[10,14,15],{},"It does not tell you what that thing is.",[10,17,18],{},"This is not a pedantic distinction. Purity and identity are genuinely separate\nquestions, they are answered by different instruments, and the gap between them\nis where substitution happens in the research peptide market.",[20,21,23],"h2",{"id":22},"what-chromatography-can-and-cannot-do","What chromatography can and cannot do",[10,25,26],{},"HPLC separates a mixture by how strongly each component interacts with a\nstationary phase. Components emerge at different times, a detector records them,\nand the result is a trace of peaks against retention time.",[10,28,29],{},"That gives you two pieces of information:",[31,32,33,41],"ul",{},[34,35,36,40],"li",{},[37,38,39],"strong",{},"Relative quantity"," — from peak area. This is what the purity percentage is.",[34,42,43,46],{},[37,44,45],{},"Retention time"," — a weak identity indicator.",[10,48,49,50,53],{},"Retention time is weak for a specific reason: ",[37,51,52],{},"it is a property of the method,\nnot of the molecule",". Change the column, the gradient, the temperature or the\nmobile phase and it changes. Two laboratories running the same peptide will get\ndifferent retention times.",[10,55,56],{},"More importantly, many different molecules share a retention time on any given\nmethod. A peptide and its single-residue deletion sequence often co-elute or\nnearly co-elute. Two members of the same analogue family frequently do. Retention\ntime can support an identification against a reference standard run on the same\nsystem that day; on its own it establishes very little.",[20,58,60],{"id":59},"what-mass-spectrometry-adds","What mass spectrometry adds",[10,62,63],{},"Mass spectrometry measures a property of the molecule itself: its mass.",[10,65,66],{},"The sample is ionised — for peptides, almost always by electrospray — and the\ninstrument measures mass-to-charge ratios of the resulting ions. Software\nconverts that to molecular mass, which is compared against the theoretical mass\ncalculated from the intended sequence.",[10,68,69],{},"That comparison is the identity test. Every amino acid has a known residue mass,\nso a sequence has an exactly calculable mass. Material that matches within\ninstrument tolerance is the compound it claims to be. Material that does not is\nsomething else, and the size of the discrepancy usually says what.",[71,72,73,86],"table",{},[74,75,76],"thead",{},[77,78,79,83],"tr",{},[80,81,82],"th",{},"Discrepancy",[80,84,85],{},"Likely cause",[87,88,89,98,106,114,122,130,138,146],"tbody",{},[77,90,91,95],{},[92,93,94],"td",{},"−57 Da",[92,96,97],{},"Missing glycine",[77,99,100,103],{},[92,101,102],{},"−71 Da",[92,104,105],{},"Missing alanine",[77,107,108,111],{},[92,109,110],{},"−113\u002F−114 Da",[92,112,113],{},"Missing leucine\u002Fisoleucine, or asparagine",[77,115,116,119],{},[92,117,118],{},"−186 Da",[92,120,121],{},"Missing tryptophan",[77,123,124,127],{},[92,125,126],{},"+16 Da",[92,128,129],{},"Oxidation (commonly methionine)",[77,131,132,135],{},[92,133,134],{},"+1 Da",[92,136,137],{},"Deamidation (asparagine → aspartate)",[77,139,140,143],{},[92,141,142],{},"−2 Da",[92,144,145],{},"Disulfide bond formed",[77,147,148,151],{},[92,149,150],{},"~2× mass",[92,152,153],{},"Dimer",[10,155,156,157,161],{},"Note how many of these are ",[158,159,160],"em",{},"small",". A +16 Da oxidation or a +1 Da deamidation\ndoes not move a peak far on a chromatogram, and may not move it at all. On a mass\nspectrum they are unambiguous.",[20,163,165],{"id":164},"where-this-matters-most","Where this matters most",[10,167,168,171],{},[37,169,170],{},"Analogue families."," Compounds in the incretin class — semaglutide,\ntirzepatide, retatrutide — share substantial structural similarity, similar\nlipidation, similar chromatographic behaviour and very different prices.\nSubstituting one for another is invisible to a purity measurement and immediately\nobvious on a mass spectrum, because the masses differ by hundreds of daltons.",[10,173,174,177],{},[37,175,176],{},"Fragment ambiguity."," \"TB-500\" refers in practice both to full-length thymosin\nβ4 (~4,963 Da) and to the Ac-LKKTETQ fragment (~889 Da). That is a factor-of-five\ndifference in mass and a much larger difference in synthesis cost. Any real MS\nresult resolves it instantly; no purity figure can.",[10,179,180,183],{},[37,181,182],{},"Form ambiguity."," \"CJC-1295\" refers to both the DAC (~3,647 Da) and non-DAC\n(~3,368 Da) forms, which behave differently in every design where receptor\noccupancy duration is a variable.",[10,185,186,189],{},[37,187,188],{},"Deletion sequences."," The impurity class chromatography handles worst, and mass\nspectrometry handles best.",[20,191,193],{"id":192},"reading-a-mass-spectrometry-result","Reading a mass spectrometry result",[10,195,196,197,200],{},"A certificate should give you ",[37,198,199],{},"both"," numbers:",[31,202,203,209],{},[34,204,205,208],{},[37,206,207],{},"Theoretical mass"," — calculated from the sequence. Arithmetic, not a result.",[34,210,211,214],{},[37,212,213],{},"Observed mass"," — what the instrument measured. The actual result.",[10,216,217],{},"Showing both lets a reader check the comparison. Showing only \"MS: confirmed\" or\nonly one figure asks the reader to take the comparison on trust, which defeats\nthe purpose of publishing it.",[219,220,222],"h3",{"id":221},"monoisotopic-versus-average-mass","Monoisotopic versus average mass",[10,224,225],{},"Two different theoretical masses can be calculated for the same molecule, and\nmixing them up produces an apparent discrepancy where there is none.",[10,227,228,231,232,235],{},[37,229,230],{},"Monoisotopic mass"," uses the lightest isotope of each element. ",[37,233,234],{},"Average mass","\nuses the isotope-weighted average. For a small peptide the difference is under a\ndalton; for a 5,000 Da peptide it can be two or three daltons.",[10,237,238],{},"A certificate should say which convention it is using. When observed and\ntheoretical differ by a small amount on a large peptide, this is the first thing\nto check.",[219,240,242],{"id":241},"multiply-charged-ions","Multiply charged ions",[10,244,245],{},"Electrospray adds protons — often several. A 4,963 Da peptide is commonly\nobserved not at 4,963 but as a series: the 3+ ion at m\u002Fz ≈ 1,655, the 4+ at\n≈ 1,242, the 5+ at ≈ 993. The instrument measures mass-to-charge, and\ndeconvolution software reconstructs the molecular mass from the series.",[10,247,248,249,252],{},"This is worth knowing because ",[37,250,251],{},"a mass spectrum of a large peptide showing a\nsingle clean peak at exactly the molecular weight is not what real electrospray\ndata looks like",". It is what someone unfamiliar with the technique would draw.",[20,254,256],{"id":255},"what-mass-spectrometry-does-not-establish","What mass spectrometry does not establish",[10,258,259],{},"Being clear about the limits matters as much as the capabilities.",[10,261,262,265],{},[37,263,264],{},"It does not distinguish stereoisomers."," D- and L-amino acids have identical\nmasses. Ipamorelin contains two D-residues, and a synthesis that incorporated the\nL-form at either position would produce a diastereomer with an identical mass\nspectrum. Only chromatography — with a method that resolves them — can see this.",[10,267,268,271],{},[37,269,270],{},"It does not distinguish leucine from isoleucine."," Identical formulas,\nidentical masses.",[10,273,274,277],{},[37,275,276],{},"It does not quantify."," Ionisation efficiency varies between species, so peak\nintensity in a mass spectrum is not proportional to abundance. Quantitation is\nchromatography's job.",[10,279,280,283],{},[37,281,282],{},"Standard MS does not confirm sequence order."," A peptide and a scrambled\nversion of the same residues have the same mass. Establishing order requires\ntandem MS (MS\u002FMS), where the molecule is fragmented and the fragment masses read\nback. This is not part of a routine release package, and a certificate claiming\n\"sequence confirmed by MS\" from a single-stage measurement is overstating what\nwas done.",[20,285,287],{"id":286},"the-two-methods-together","The two methods together",[10,289,290],{},"Neither instrument answers the whole question.",[10,292,293,296],{},[37,294,295],{},"HPLC"," establishes how much of the material is the main component, and — with a\nchromatogram you can actually see — what the impurity profile looks like.",[10,298,299,302],{},[37,300,301],{},"Mass spectrometry"," establishes that the main component is the intended\nmolecule.",[10,304,305],{},"A certificate with both has addressed purity and identity. A certificate with\npurity alone has established that a vial contains 99% of something, and left the\nmore consequential question open.",[10,307,308,309,314,315,319],{},"Related: ",[310,311,313],"a",{"href":312},"\u002Fresearch\u002Fhow-to-read-a-peptide-coa","how to read a peptide COA"," and\n",[310,316,318],{"href":317},"\u002Fresearch\u002Finterpreting-hplc-chromatograms","reading an HPLC chromatogram",".",{"title":321,"searchDepth":322,"depth":322,"links":323},"",2,[324,325,326,327,332,333],{"id":22,"depth":322,"text":23},{"id":59,"depth":322,"text":60},{"id":164,"depth":322,"text":165},{"id":192,"depth":322,"text":193,"children":328},[329,331],{"id":221,"depth":330,"text":222},3,{"id":241,"depth":330,"text":242},{"id":255,"depth":322,"text":256},{"id":286,"depth":322,"text":287},"Purity and identity are different questions requiring different instruments. Why a chromatogram alone cannot tell you which peptide is in the vial, and what a mass spectrum on a COA should actually show.","md",[337,340,343],{"question":338,"answer":339},"Can HPLC identify a peptide?","Not on its own. Chromatography separates components and reports how much of each is present, using retention time as a weak identity indicator. Retention time is method-dependent and shared by many similar molecules, so it can support an identification but cannot establish one. Mass spectrometry measures the molecular mass directly, which is a property of the molecule rather than of the method.",{"question":341,"answer":342},"What is a multiply charged ion and why do peptide mass spectra show them?","Electrospray ionisation adds several protons to a peptide, so a 5,000 Da peptide might be observed at m\u002Fz 1,251 as the 4+ ion rather than at 5,000. The instrument measures mass-to-charge ratio, not mass, and the software deconvolutes the resulting series back to a single molecular mass. A peptide spectrum showing a single clean peak at the exact molecular weight is not what a real electrospray spectrum of a large peptide looks like.",{"question":344,"answer":345},"How close should observed and theoretical mass be?","It depends on the instrument. A routine low-resolution instrument might be quoted to within roughly one dalton; a high-resolution instrument to within a few parts per million. What matters is that the certificate states both figures and that the difference is consistent with the instrument type — a claimed accuracy far tighter than the stated instrument can deliver is itself a warning sign.",{},true,"\u002Fresearch\u002Fmass-spectrometry-peptide-identity","2026-08-19",8,[352,353,354],"tb-500","tirzepatide","aod-9604",{"title":5,"description":334},"research\u002Fmass-spectrometry-peptide-identity",[358,359,360,361],"mass spectrometry","identity","COA","quality control",null,"H0_ziPWBfoXF_KpfB0XS2Nel-hxFNOAzANoTwBd5F-Y",[365,373,380],{"path":366,"name":367,"alsoKnownAs":368,"summary":369,"category":370,"molecularWeight":371,"purity":372},"\u002Fcompounds\u002Faod-9604","AOD-9604","hGH fragment 176-191","A synthetic fragment of the human growth hormone C-terminus, studied for lipolytic activity separated from the growth-promoting effects of the full hormone.","Growth Hormone","~1,815 Da","≥99%",{"path":374,"name":375,"alsoKnownAs":376,"summary":377,"category":378,"molecularWeight":379,"purity":372},"\u002Fcompounds\u002Ftb-500","TB-500","Thymosin β4 · Tβ4","A synthetic form of thymosin beta-4, the principal actin-sequestering peptide in mammalian cells, studied in cell migration and tissue repair models.","Repair & Recovery","~4,963 Da",{"path":381,"name":382,"alsoKnownAs":383,"summary":384,"category":385,"molecularWeight":386,"purity":372},"\u002Fcompounds\u002Ftirzepatide","Tirzepatide","LY3298176 · GIP\u002FGLP-1 dual agonist","A dual GIP and GLP-1 receptor agonist, the second-generation incretin analogue and the reference compound for comparative metabolic work.","Metabolic","~4,813 Da",[388,393,398],{"path":389,"title":390,"description":391,"publishedAt":392},"\u002Fresearch\u002Fchoosing-a-peptide-supplier-australia","Choosing a Research Peptide Supplier in Australia: A Checklist","Fourteen questions that separate suppliers with a real quality process from suppliers with a good website — covering documentation, testing claims, provenance, handling and the language they use.","2026-08-24",{"path":394,"title":395,"description":396,"publishedAt":397},"\u002Fresearch\u002Fcounterfeit-peptides-australia","Counterfeit and Substituted Research Peptides: What Actually Gets Faked","Substitution, dilution, wrong-form supply and underfilled vials — the four ways research peptides are misrepresented, why each is hard to detect, and which analytical test catches which.","2026-08-23",{"path":399,"title":400,"description":401,"publishedAt":397},"\u002Fresearch\u002Fresearch-peptides-australia-legal-status","Research Peptides in Australia: The Regulatory Position","How the TGA, the Poisons Standard and import rules apply to peptides supplied for laboratory research in Australia — what research-use-only means legally, and where the line sits.",1787473952822]